Product Categories
Country: | United States |
---|---|
Tel: | +1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
EMDT oxalate | C15H22N2O | 263744-72-5 | Details |
EG00229 | C19H20F3N7O7S3 | 1210945-69-9 | Details |
Ecopladib;PLA 725 | C39H33Cl3N2O5S | 381683-92-7 | Details |
eIF4A3-IN-2 | C25H19Br2ClN4O2 | 2095677-20-4 | Details |
E-7386 | C39H48FN9O4 | 1799824-08-0 | Details |
Elenbecestat;E2609 | C19H18F3N5O2S | 1388651-30-6 | Details |
EGFR-IN-7;TQB3804 | C32H41BrN9O2P | 2267329-76-8 | Details |
Ciclopirox olamine;Ciclopirox ethanolamine | C14H24N2O3 | 41621-49-2 | Details |
E64FC26 | C19H23F3O2 | 2285446-62-8 | Details |
EML741 | C31H49N5O2 | 2328074-38-8 | Details |
DuP 105 | C13H16N2O4S | 96800-41-8 | Details |
Endoxifen (E-isomer);Endoxifen E-isomer;E-Endoxifen | C25H27NO2 | 114828-90-9 | Details |
Dutogliptin;PHX-1149 free base | C10H20BN3O3 | 852329-66-9 | Details |
Duocarmycin MB | C27H26ClN3O4 | 1613286-58-0 | Details |
Nazartinib S-enantiomer;EGF816 (S-enantiomer) | C26H31ClN6O2 | 1508256-20-9 | Details |
Dutogliptin tartrate;PHX-1149 | C14H26BN3O9 | 890402-81-0 | Details |
Clorgyline hydrochloride;Clorgiline hydrochloride | C13H16Cl3NO | 17780-75-5 | Details |
DVD-445 | C25H28F2N2O4 | 2375846-41-4 | Details |
Enalapril D5 maleate;MK-421 D5 maleate | C24H27D5N2O9 | 349554-02-5 | Details |
Emtricitabine S-oxide;Emtricitabine sulfoxide;Emtricitabine Degradant-III | C8H10FN3O4S | 152128-77-3 | Details |
EMD638683 S-Form | C18H18F2N2O4 | 1184940-46-2 | Details |
Eliglustat hemitartrate;Genz-112638;Eliglustat tartrate | C50H78N4O14 | 928659-70-5 | Details |
DUB-IN-2 | C15H9N5O | 924296-19-5 | Details |
Rasagiline;TVP1012;AGN1135 | C12H13N | 136236-51-6 | Details |
DUPA(OtBu)-OH | C23H40N2O9 | 1026987-94-9 | Details |
EGFR-IN-2 | C26H33N9O3S | 1643497-70-4 | Details |
Endomorphin 2 TFA | C34H38F3N5O7 | 1276124-00-5 | Details |
Cefprozil monohydrate;Cefprozil;Cefprozil hydrate | C18H21N3O6S | 121123-17-9 | Details |
Enniatin A1 | C35H61N3O9 | 4530-21-6 | Details |
2-(Hydroxymethyl)pyridine;Piconol | C6H7NO | 586-98-1 | Details |
EMPA | C23H26N4O4S | 680590-49-2 | Details |
Biotin;D-Biotin;Vitamin H;Vitamin B7 | C10H16N2O3S | 58-85-5 | Details |
Ecteinascidin-Analog-1 | C31H44N2O9 | 874758-58-4 | Details |
Ecteinascidin 770;Et-770;Ecteinascidine 770 | C40H42N4O10S | 114899-80-8 | Details |
EACC | C13H11N3O6S2 | 864941-31-1 | Details |
Duocarmycin MA | C34H31ClN4O5 | 1613286-57-9 | Details |
EHMT2-IN-1 | C18H23N7O | 2230849-55-3 | Details |
(E/Z)-BCI;NSC 150117 | C22H23NO | 15982-84-0 | Details |
DW14800 | C31H36N4O3 | 2243709-60-4 | Details |
EB-47 | C24H27N9O6 | 366454-36-6 | Details |
Endothelial lipase inhibitor-1 | C22H22N4O4 | 1466427-02-0 | Details |
EC1454 | C65H98N16O34S | 1602487-15-9 | Details |
Eg5 Inhibitor V, trans-24 | C26H21N3O3 | 869304-55-2 | Details |
Imazalil;Enilconazole;chloramizole | C14H14Cl2N2O | 35554-44-0 | Details |
Duocarmycin DM free base;Duocarmycin | C26H26ClN3O3 | 1116745-06-2 | Details |
Duocarmycin TM | C25H23ClN2O5 | 157922-77-5 | Details |
ELN318463 racemate;ELN 318463 racemate | C19H20BrClN2O3S | 851599-82-1 | Details |
eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
Elubrixin;SB-656933 | C17H17Cl2FN4O4S | 688763-64-6 | Details |
EC5026;BPN-19186 | C18H23F4N3O3 | 1809885-32-2 | Details |
DYRKs-IN-1 | C30H30ClN7O4 | 1387090-01-8 | Details |
Enazadrem | C18H25N3O | 107361-33-1 | Details |
(R)-Elagolix;NBI-56418 | C32H30F5N3O5 | 834153-87-6 | Details |
ELN318463;ELN 318463 | C19H20BrClN2O3S | 851600-86-7 | Details |
EMD638683 R-Form | C18H18F2N2O4 | 1184940-47-3 | Details |
DZ2002 | C10H13N5O3 | 33231-14-0 | Details |
Duocarmycin GA | C26H25ClN4O3 | 1613286-59-1 | Details |
Duvelisib (R enantiomer);INK1197 R enantiomer;Duvelisib R enantiomer;IPI-145 R enantiomer | C22H17ClN6O | 1261590-48-0 | Details |
Durlobactam sodium salt;ETX2514 | C8H12N3NaO6S | 1467157-21-6 | Details |
LHF-535 | C27H28N2O2 | 1450929-77-7 | Details |
EGFR-IN-8 | C32H23ClF3N7O4 | 2407957-87-1 | Details |
Duocarmycin SA | C25H23N3O7 | 130288-24-3 | Details |
DUB-IN-3 | C16H9N5O | 924296-17-3 | Details |
Elinogrel;PRT060128 | C20H15ClFN5O5S2 | 936500-94-6 | Details |
EGFR-IN-9 | C29H24N4O3 | 1226549-39-8 | Details |
Enniatin complex | C36H63N3O9.C35H61N3O9.C34H59N3O9.C33H57N3O9 | 11113-62-5 | Details |
EHMT2-IN-2 | C21H22N6O | 2230850-47-0 | Details |
(E)-GABAB receptor antagonist 1 | C18H24O4 | 1611483-29-4 | Details |
EGFR-IN-1 | C28H30N6O4 | 1625677-63-5 | Details |
Duoperone | C28H26F4N2OS | 62030-88-0 | Details |
Enalaprilat D5;MK-422 D5 | C18H19D5N2O5 | 349554-00-3 | Details |
EHNA hydrochloride | C14H24ClN5O | 58337-38-5 | Details |
(E)-10-Hydroxynortriptyline maleate;(E)-10-Hydroxy Nortriptyline maleate | C23H25NO5 | 74853-74-0 | Details |
Emixustat;ACU-4429 | C16H25NO2 | 1141777-14-1 | Details |
E6130 | C28H37ClF3N3O3 | 1427058-33-0 | Details |
EC359 | C36H38F2O2 | 2012591-09-0 | Details |
EG01377 | C26H30N6O6S2 | 2227996-00-9 | Details |
Enalaprilat-d5 sodium;Enalaprilat D5 Sodium Salt;MK-422 D5 Sodium Salt | C18H18D5N2NaO5 | 1356922-29-6 | Details |
Dacarbazine;DTIC-Dome;Imidazole Carboxamide | C6H10N6O | 4342-03-4 | Details |
DYRKs-IN-2 | C32H38ClN9O3 | 1386980-04-6 | Details |
EML4-ALK kinase inhibitor 1;EML4-?ALK kinase inhibitor 1 | C31H48N8O3 | 1373409-08-5 | Details |
Duramycin;Moli1901;Lancovutide | C89H125N23O25S3 | 1391-36-2 | Details |
EGLU;(2S)-α-Ethylglutamic acid;(2S)-α-EGLU | C7H13NO4 | 170984-72-2 | Details |
Emixustat hydrochloride;ACU-4429 hydrochloride | C16H26ClNO2 | 1141934-97-5 | Details |
Durvalumab;MEDI 4736 | 1428935-60-7 | Details |
Nazartinib mesylate;EGF816 (mesylate) | C27H35ClN6O5S | 1508250-72-3 | Details |
EN6 | C19H14F2N4O2 | 1808714-73-9 | Details |
EGFR-IN-5 | C31H38FN9O | 2225887-26-1 | Details |
EC0488 | C65H98N16O34S | 1059477-92-7 | Details |
EMT inhibitor-2 | C24H26N2O8 | 2232228-60-1 | Details |
Duloxetine D3 hydrochloride;LY248686 D3 hydrochloride;(S)-Duloxetine D3 hydrochloride | C18H20ClNOS | 1435727-97-1 | Details |
Ecastolol | C26H33N3O6 | 77695-52-4 | Details |
Eicosatetraynoic acid;ETYA | C20H24O2 | 1191-85-1 | Details |
Duloxetine metabolite Para-Naphthol Duloxetine;Para-Naphthol duloxetine | C18H19NOS | 949095-98-1 | Details |
EMT inhibitor-1 | C12H12Cl2N2O2S | 1638526-21-2 | Details |
Doxylamine succinate;Decapryn | C21H28N2O5 | 562-10-7 | Details |
Edaravone-d5;MCI-186 D5;Edaravone D5 | C10H10N2O | 1228765-67-0 | Details |
EIPA hydrochloride;L593754 hydrochloride;MH 12-43 hydrochloride | C11H19Cl2N7O | 1345839-28-2 | Details |
EGFR-IN-1 hydrochloride | C28H31ClN6O4 | 2227455-78-7 | Details |
Embramine | C18H22BrNO | 3565-72-8 | Details |
Product Total: Product Page: | ||||
2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 |